Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.570
-0.130 (-3.51%)
Sep 8, 2026, 12:10 PM EDT - Market open
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $635.12 million as of September 8, 2026. Its market cap has increased by 1.01% in one year.
Market Cap
635.12M
Enterprise Value
652.53M
1-Year Change
1.01%
Ranking
Category
Stock Price
$3.57
ChartMarket Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $635.12M, a decrease of -60.97%. That is a compound annual growth rate of -21.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 635.12M | 3.39% |
| Dec 31, 2025 | 614.32M | 64.88% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
| Oct 20, 2022 | 1.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shattuck Labs | 681.47M |
| Allogene Therapeutics | 680.62M |
| Sagimet Biosciences | 680.02M |
| BlossomHill Therapeutics | 674.47M |
| MiMedx Group | 666.13M |
| Altimmune | 665.25M |
| CorMedix | 657.07M |
| Bright Minds Biosciences | 656.57M |